The Market Reports

Index

1 Favipiravir Market Overview
1.1 Product Overview and Scope of Favipiravir
1.2 Favipiravir Segment by Type
1.2.1 Global Favipiravir Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Favipiravir Segment by Application
1.3.1 Global Favipiravir Sales Comparison by Application: (2021-2027)
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Market Size Estimates and Forecasts
1.4.1 Global Favipiravir Revenue 2016-2027
1.4.2 Global Favipiravir Sales 2016-2027
1.4.3 Favipiravir Market Size by Region: 2016 Versus 2021 Versus 2027

2 Favipiravir Market Competition by Manufacturers
2.1 Global Favipiravir Sales Market Share by Manufacturers (2016-2021)
2.2 Global Favipiravir Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Favipiravir Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Favipiravir Manufacturing Sites, Area Served, Product Type
2.5 Favipiravir Market Competitive Situation and Trends
2.5.1 Favipiravir Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Favipiravir Players Market Share by Revenue
2.5.3 Global Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Favipiravir Retrospective Market Scenario by Region
3.1 Global Favipiravir Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Favipiravir Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Favipiravir Market Facts & Figures by Country
3.3.1 North America Favipiravir Sales by Country
3.3.2 North America Favipiravir Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Favipiravir Market Facts & Figures by Country
3.4.1 Europe Favipiravir Sales by Country
3.4.2 Europe Favipiravir Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Favipiravir Market Facts & Figures by Region
3.5.1 Asia Pacific Favipiravir Sales by Region
3.5.2 Asia Pacific Favipiravir Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Favipiravir Market Facts & Figures by Country
3.6.1 Latin America Favipiravir Sales by Country
3.6.2 Latin America Favipiravir Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Favipiravir Market Facts & Figures by Country
3.7.1 Middle East and Africa Favipiravir Sales by Country
3.7.2 Middle East and Africa Favipiravir Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Favipiravir Historic Market Analysis by Type
4.1 Global Favipiravir Sales Market Share by Type (2016-2021)
4.2 Global Favipiravir Revenue Market Share by Type (2016-2021)
4.3 Global Favipiravir Price by Type (2016-2021)

5 Global Favipiravir Historic Market Analysis by Application
5.1 Global Favipiravir Sales Market Share by Application (2016-2021)
5.2 Global Favipiravir Revenue Market Share by Application (2016-2021)
5.3 Global Favipiravir Price by Application (2016-2021)

6 Key Companies Profiled
6.1 ChemRar Group
6.1.1 ChemRar Group Corporation Information
6.1.2 ChemRar Group Description and Business Overview
6.1.3 ChemRar Group Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ChemRar Group Favipiravir Product Portfolio
6.1.5 ChemRar Group Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Corporation Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glenmark Favipiravir Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Corporation Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Fujifilm Favipiravir Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Dr. Reddy
6.4.1 Dr. Reddy Corporation Information
6.4.2 Dr. Reddy Description and Business Overview
6.4.3 Dr. Reddy Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dr. Reddy Favipiravir Product Portfolio
6.4.5 Dr. Reddy Recent Developments/Updates
6.5 R-Pharma
6.5.1 R-Pharma Corporation Information
6.5.2 R-Pharma Description and Business Overview
6.5.3 R-Pharma Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.5.4 R-Pharma Favipiravir Product Portfolio
6.5.5 R-Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Cipla Favipiravir Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lupin Favipiravir Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Corporation Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sun Pharma Favipiravir Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hisun Pharm
6.9.1 Hisun Pharm Corporation Information
6.9.2 Hisun Pharm Description and Business Overview
6.9.3 Hisun Pharm Favipiravir Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hisun Pharm Favipiravir Product Portfolio
6.9.5 Hisun Pharm Recent Developments/Updates

7 Favipiravir Manufacturing Cost Analysis
7.1 Favipiravir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Favipiravir
7.4 Favipiravir Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Favipiravir Distributors List
8.3 Favipiravir Customers

9 Favipiravir Market Dynamics
9.1 Favipiravir Industry Trends
9.2 Favipiravir Growth Drivers
9.3 Favipiravir Market Challenges
9.4 Favipiravir Market Restraints

10 Global Market Forecast
10.1 Favipiravir Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Favipiravir by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Favipiravir by Type (2022-2027)
10.2 Favipiravir Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Favipiravir by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Favipiravir by Application (2022-2027)
10.3 Favipiravir Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Favipiravir by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Favipiravir by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Favipiravir Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Favipiravir Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Favipiravir Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Favipiravir Covered in This Study
Table 5. Global Favipiravir Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Favipiravir Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Favipiravir Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Favipiravir Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Favipiravir Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Favipiravir Manufacturing Sites and Area Served
Table 11. Manufacturers Favipiravir Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Favipiravir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Favipiravir as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Favipiravir Sales by Region (2016-2021) & (K Units)
Table 16. Global Favipiravir Sales Market Share by Region (2016-2021)
Table 17. Global Favipiravir Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Favipiravir Sales by Country (2016-2021) & (K Units)
Table 19. North America Favipiravir Sales Market Share by Country (2016-2021)
Table 20. North America Favipiravir Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Favipiravir Revenue Market Share by Country (2016-2021)
Table 22. Europe Favipiravir Sales by Country (2016-2021) & (K Units)
Table 23. Europe Favipiravir Sales Market Share by Country (2016-2021)
Table 24. Europe Favipiravir Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Favipiravir Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Favipiravir Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Favipiravir Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Favipiravir Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Favipiravir Revenue Market Share by Region (2016-2021)
Table 30. Latin America Favipiravir Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Favipiravir Sales Market Share by Country (2016-2021)
Table 32. Latin America Favipiravir Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Favipiravir Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Favipiravir Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Favipiravir Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Favipiravir Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Favipiravir Revenue Market Share by Country (2016-2021)
Table 38. Global Favipiravir Sales (K Units) by Type (2016-2021)
Table 39. Global Favipiravir Sales Market Share by Type (2016-2021)
Table 40. Global Favipiravir Revenue (Million US$) by Type (2016-2021)
Table 41. Global Favipiravir Revenue Share by Type (2016-2021)
Table 42. Global Favipiravir Price (US$/Unit) by Type (2016-2021)
Table 43. Global Favipiravir Sales (K Units) by Application (2016-2021)
Table 44. Global Favipiravir Sales Market Share by Application (2016-2021)
Table 45. Global Favipiravir Revenue (Million US$) by Application (2016-2021)
Table 46. Global Favipiravir Revenue Share by Application (2016-2021)
Table 47. Global Favipiravir Price (US$/Unit) by Application (2016-2021)
Table 48. ChemRar Group Corporation Information
Table 49. ChemRar Group Description and Business Overview
Table 50. ChemRar Group Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. ChemRar Group Favipiravir Product
Table 52. ChemRar Group Recent Developments/Updates
Table 53. Glenmark Corporation Information
Table 54. Glenmark Description and Business Overview
Table 55. Glenmark Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Glenmark Favipiravir Product
Table 57. Glenmark Recent Developments/Updates
Table 58. Fujifilm Corporation Information
Table 59. Fujifilm Description and Business Overview
Table 60. Fujifilm Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Fujifilm Favipiravir Product
Table 62. Fujifilm Recent Developments/Updates
Table 63. Dr. Reddy Corporation Information
Table 64. Dr. Reddy Description and Business Overview
Table 65. Dr. Reddy Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Dr. Reddy Favipiravir Product
Table 67. Dr. Reddy Recent Developments/Updates
Table 68. R-Pharma Corporation Information
Table 69. R-Pharma Description and Business Overview
Table 70. R-Pharma Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. R-Pharma Favipiravir Product
Table 72. R-Pharma Recent Developments/Updates
Table 73. Cipla Corporation Information
Table 74. Cipla Description and Business Overview
Table 75. Cipla Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Cipla Favipiravir Product
Table 77. Cipla Recent Developments/Updates
Table 78. Lupin Corporation Information
Table 79. Lupin Description and Business Overview
Table 80. Lupin Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Lupin Favipiravir Product
Table 82. Lupin Recent Developments/Updates
Table 83. Sun Pharma Corporation Information
Table 84. Sun Pharma Description and Business Overview
Table 85. Sun Pharma Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Sun Pharma Favipiravir Product
Table 87. Sun Pharma Recent Developments/Updates
Table 88. Hisun Pharm Corporation Information
Table 89. Hisun Pharm Description and Business Overview
Table 90. Hisun Pharm Favipiravir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Hisun Pharm Favipiravir Product
Table 92. Hisun Pharm Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Favipiravir Distributors List
Table 96. Favipiravir Customers List
Table 97. Favipiravir Market Trends
Table 98. Favipiravir Growth Drivers
Table 99. Favipiravir Market Challenges
Table 100. Favipiravir Market Restraints
Table 101. Global Favipiravir Sales Forecast by Type (2022-2027) & (K Units)
Table 102. Global Favipiravir Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Favipiravir Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Favipiravir Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Favipiravir Sales Forecast by Application (2022-2027) & (K Units)
Table 106. Global Favipiravir Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Favipiravir Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Favipiravir Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Favipiravir Sales Forecast by Region (2022-2027) & (K Units)
Table 110. Global Favipiravir Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Favipiravir Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Favipiravir Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Favipiravir
Figure 2. Global Favipiravir Market Share by Type in 2020 & 2027
Figure 3. Brand Drug Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Favipiravir Market Share by Application in 2020 & 2027
Figure 6. Influenza Viruses
Figure 7. COVID-19
Figure 8. Others
Figure 9. Global Favipiravir Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Favipiravir Market Size 2016-2027 (US$ Million)
Figure 11. Global Favipiravir Sales 2016-2027 (K Units)
Figure 12. Global Favipiravir Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Favipiravir Sales Share by Manufacturers in 2020
Figure 14. Global Favipiravir Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Favipiravir Players: Market Share by Revenue in 2020
Figure 16. Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Favipiravir Sales Market Share by Region (2016-2021)
Figure 18. Global Favipiravir Sales Market Share by Region in 2020
Figure 19. Global Favipiravir Revenue Market Share by Region (2016-2021)
Figure 20. Global Favipiravir Revenue Market Share by Region in 2020
Figure 21. United States Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Favipiravir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Favipiravir by Type (2016-2021)
Figure 44. Sales Market Share of Favipiravir by Application (2016-2021)
Figure 45. Sales Market Share of Favipiravir by Application in 2020
Figure 46. Revenue Share of Favipiravir by Application (2016-2021)
Figure 47. Revenue Share of Favipiravir by Application in 2020
Figure 48. Manufacturing Cost Structure of Favipiravir
Figure 49. Manufacturing Process Analysis of Favipiravir
Figure 50. Favipiravir Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed